FDA product code SJA: Injectable For Thermal Treatment Of Musculoskeletal Pain

SJA is the FDA product code for injectable for thermal treatment of musculoskeletal pain. It is a Class II device, regulated under 21 CFR 888.3048 and reviewed by the Orthopedic panel. Devices under SJA reach the market by 510(k); FDA lists no cleared 510(k)s for it. 1 De Novo request was granted under it.

Definition

An injectable for thermal treatment of musculoskeletal pain is an injectable device intended to inhibit sensory nerve signaling through exchange of thermal energy (e.g., cold temperatures). The device is injected into the extraneural space of the target nerve.

Classification

FieldValue
Device nameInjectable For Thermal Treatment Of Musculoskeletal Pain
Device classClass II
Regulation21 CFR 888.3048
Review panelOR — Orthopedic
Medical specialtyOrthopedic
Premarket route510(k)

Recalls for SJA devices

FDA recall records list no recalls for product code SJA.

Frequently asked questions

What is FDA product code SJA?

SJA is the FDA product code for injectable for thermal treatment of musculoskeletal pain. It is a Class II device, regulated under 21 CFR 888.3048 and reviewed by the Orthopedic panel.

What device class is SJA?

Class II, regulation 21 CFR 888.3048. Typical premarket route: 510(k).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Orthopedic product codes · FDA product code lookup · 510(k) database search · 510(k) review times